Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
Neurotoxicity Research - United States
doi 10.1007/s12640-017-9781-2
Full Text
Open PDFAbstract
Available in full text
Date
July 21, 2017
Authors
Publisher
Springer Science and Business Media LLC